Product Information
LEVOCETIRIZINE 2.5 MG/5 ML SOL is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $0.1555 per ML under NDC 45802068028. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
.5 mg/mL
Manufacturer
Padagis Israel Pharmaceuticals LtdNDC
45802068028
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
LEVOCETIRIZINE DIHYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA091263On Market Since
11/7/2011
Pharmacological Classes
Price Statistics
The NADAC for LEVOCETIRIZINE 2.5 MG/5 ML SOL has been published 657 times since Nov 28, 2013, and over the history we have for it it has declined 63.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1555 per ML |
|---|---|
| All-time high | $0.5031 (Apr 15, 2015) |
| All-time low | $0.1171 (Sep 22, 2021) |
| 52-week high | $0.1807 |
| 52-week low | $0.1409 |
| Median price | $0.3191 |
| Average price | $0.3204 |
| Largest weekly change | +68.3% (Dec 22, 2021) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Levocetirizine dihydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of LEVOCETIRIZINE 2.5 MG/5 ML SOL?
The current National Average Drug Acquisition Cost (NADAC) for LEVOCETIRIZINE 2.5 MG/5 ML SOL, manufactured by Padagis Israel Pharmaceuticals Ltd, is $0.1555 per ML (NDC 45802068028), effective Jun 24, 2026.
How has the price of LEVOCETIRIZINE 2.5 MG/5 ML SOL changed over time?
Over the history we have for it, the NADAC for LEVOCETIRIZINE 2.5 MG/5 ML SOL has declined 63.1%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for LEVOCETIRIZINE 2.5 MG/5 ML SOL?
Since Nov 28, 2013, the NADAC for LEVOCETIRIZINE 2.5 MG/5 ML SOL has ranged from a low of $0.1171 (Sep 22, 2021) to a high of $0.5031 (Apr 15, 2015), with a median of $0.3191 per ML.
Are there cheaper alternatives to LEVOCETIRIZINE 2.5 MG/5 ML SOL?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of LEVOCETIRIZINE 2.5 MG/5 ML SOL, so no direct lower-cost alternative is listed.
Who manufactures LEVOCETIRIZINE 2.5 MG/5 ML SOL?
LEVOCETIRIZINE 2.5 MG/5 ML SOL (NDC 45802068028) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.
Related Drugs
Same classification